Molecular biology of mesothelioma: Implications for the development of new targeted therapies

Speaker: Marc Ladanyi

Marc Ladanyi explores the basic biological processes disrupted in mesothelioma that could be utilized for targeting in the clinic. He elaborates on genetic alterations research efforts and genomic technologies that could lead to advances in the treatment of this disease.

Discussion Points

  • Where do we stand in molecular biology application?
  • Future targets
  • Cancer genome atlas efforts